GlaxoSmithKline
GSK
$37.28
Share price
-1.14%
Change (1 day)
-8.67%
Change (1 year)
Categories
GlaxoSmithKline (GSK) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $59.66 B
According to GlaxoSmithKline's latest financial reports the company's total liabilities are $59.66 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
GlaxoSmithKline - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $60.66 B | -22.2% |
| 2021-12-31 | $77.96 B | -4.06% |
| 2020-12-31 | $81.27 B | 1.05% |
| 2019-12-31 | $80.42 B | 16.49% |
| 2018-12-31 | $69.04 B | -3.42% |
| 2017-12-31 | $71.48 B | 6.97% |
| 2016-12-31 | $66.83 B | 1.19% |
| 2015-12-31 | $66.04 B | 18.78% |
| 2014-12-31 | $55.60 B | -1.65% |
| 2013-12-31 | $56.53 B | 0.72% |
| 2012-12-31 | $56.13 B | 12.19% |
| 2011-12-31 | $50.03 B | 0.32% |
| 2010-12-31 | $49.87 B | -4.05% |
| 2009-12-31 | $51.97 B | 14.12% |
| 2008-12-31 | $45.54 B | 8.69% |
| 2007-12-31 | $41.90 B | 34.13% |
| 2006-12-31 | $31.24 B | -7.42% |
| 2005-12-31 | $33.74 B | 3.35% |
| 2004-12-31 | $32.64 B | 18.55% |
| 2003-12-31 | $27.54 B | 45.34% |
| 2002-12-31 | $18.94 B | 10.1% |
| 2001-12-31 | $17.21 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $59.04 B | -1.04% | 🇨🇭 Switzerland |
 Pfizer PFE | $94.38 B | 58.17% | 🇺🇸 USA |
 Sanofi SNY | $56.95 B | -4.55% | 🇫🇷 France |
 Merck MRK | $60.89 B | 2.05% | 🇺🇸 USA |
 AstraZeneca AZN | $59.12 B | -0.91% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $35.38 B | -40.70% | 🇮🇱 Israel |
 Dynavax Technologies
DVAX | $0.35 B | -99.40% | 🇺🇸 USA |